Search Results - "HERZIG, G"

Technology and its impact in the classroom by Muir-Herzig, Rozalind G

“…Recent findings have shown that at-risk students in grades k-12 are being deprived of challenges and of the chance to use complex thinking skills. The purpose…”
Get full text

Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics by CALIGIURI, M. A, STROUT, M. P, DE LA CHAPELLE, A, ELONEN, E, BLOCK, A. W, NAGESH RAO, P, HERZIG, G. P, POWELL, B. L, RUUTU, T, SCHIFFER, C. A, BLOOMFIELD, C. D, LAWRENCE, D, ARTHUR, D. C, BAER, M. R, YU, F, KNUUTILA, S, MROZEK, K, OBERKIRCHER, A. R, MARCUCCI, G

“…Approximately 45% of adults with acute myeloid leukemia (AML) have normal cytogenetics and therefore lack structural abnormalities that can assist in the…”
Get full text

Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome by Schriber, J R, Herzig, G P

Get more information

Thermostable DNA Polymerase Chain Amplification of t(14;18) Chromosome Breakpoints and Detection of Minimal Residual Disease by Crescenzi, Macro, Seto, Masao, Herzig, Geoffrey P., Weiss, Peter D., Griffith, Rogers C., Korsmeyer, Stanley J.

“…Achieving the capacity to detect minimal numbers of neoplastic cells is a major cancer diagnostic challenge. Chromosomal translocations such as the…”
Get full text

Persistence of the AML1/ETO Fusion Transcript in Patients Treated With Allogeneic Bone Marrow Transplantation for t(8;21) Leukemia by Jurlander, Jesper, Caligiuri, Michael A., Ruutu, Tapani, Baer, Maria R., Strout, Matthew P., Oberkircher, Adam R., Hoffmann, Lise, Ball, Edward D., Frei-Lahr, Debra A., Christiansen, Neal P., Block, AnneMarie W., Knuutila, Sakari, Herzig, Geoffrey P., Bloomfield, Clara D.

“…The AML1/ETO fusion transcript is expressed in virtually all patients with t(8;21)(q22;q22) acute myeloid leukemia (AMD. The fusion transcript can be detected…”
Get full text

Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11 by CALIGIURI, M. A, STROUT, M. P, TAPIO NOUSIAINEN, TAPANI RUUTU, BLOCK, A. M. W, SCHULMAN, P, PEDERSEN-BJERGAARD, J, CROCE, C. M, BLOOMFIELD, C. D, SCHICHMAN, S. A, MROZEK, K, ARTHUR, D. C, HERZIG, G. P, BAER, M. R, SCHIFFER, C. A, HEINONEN, K, SAKARI KNUUTILA

“…Gains of a single chromosome are frequent cytogenic findings in human cancer, but no molecular rearrangement has been consistently associated with any trisomy…”
Get full text

Selective inhibitors of CYP24: mechanistic tools to explore vitamin D metabolism in human keratinocytes by Schuster, I, Egger, H, Astecker, N, Herzig, G, Schüssler, M, Vorisek, G

“…Human keratinocytes are fully competent cells of the vitamin D (VD) hormone system. They have the capacity to generate VD, to convert it to hormonally active…”
Get full text

Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation : possible beneficial use of low molecular weight heparin by SIMON, M, HAHN, T, SLACK, J. L, WETZLER, M, HERZIG, G, SCHRIBER, J, MCCARTHY, P. L, FORD, L. A, ANDERSON, B, SWINNICH, D, BAER, M. R, BAMBACH, B, BERNSTEIN, S. H, BERNSTEIN, Z. P, CZUCZMAN, M. S

“…This retrospective cohort study of 462 consecutive adult allogeneic and autologous blood or marrow transplantation (BMT) patients compared the incidence of…”
Get full text

Selective inhibition of vitamin D hydroxylases in human keratinocytes by Schuster, I, Egger, H, Bikle, D, Herzig, G, Reddy, G.S, Stuetz, A, Stuetz, P, Vorisek, G

“…Human keratinocytes convert 25(OH)D 3 to hormonally active 1α,25(OH) 2D 3 and respond to its antiproliferative/prodifferentiating action in vitro and in vivo…”
Get full text

Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations by CALIGIURI, M. A, SCHICHMAN, S. A, STROUT, M. P, MROZEK, K, BAER, M. R, FRANKEL, S. R, BARCOS, M, HERZIG, G. P, CROCE, C. M, BLOOMFIELD, C. D

“…Translocations which involve chromosome band 11q23 are frequently found in infants and adults with acute myeloid leukemia (AML) or acute lymphoblastic…”
Get full text

Severe cerebellar swelling and thrombotic thrombocytopenic purpura associated with FK506 by TEZCAN, H, ZIMMER, W, FENSTERMAKER, R, HERZIG, G. P, SCHRIBER, J

“…Two patients with CsA-associated neurotoxicity developed severe cerebellar swelling and thrombotic thrombocytopenic purpura after switching to FK506 and…”
Get full text

High-Dose Etoposide, Cyclophosphamide, and Total Body Irradiation With Allogeneic Bone Marrow Transplantation for Patients With Acute Myeloid Leukemia in Untreated First Relapse: A Study by the North American Marrow Transplant Group by Brown, R.A., Wolff, S.N., Fay, J.W., Pineiro, L., Collins, R.H., Lynch, J.P., Stevens, D., Greer, J., Herzig, R.H., Herzig, G.P.

“…Relapse is a major cause of treatment failure following allogeneic bone marrow transplantation (BMT) for acute myeloid leukemia (AMD. To reduce the risk of…”
Get full text

Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin by Reece, D E, Frei-Lahr, D A, Shepherd, J D, Dorovini-Zis, K, Gascoyne, R D, Graeb, D A, Spinelli, J J, Barnett, M J, Klingemann, H G, Herzig, G P

“…Regimens using cyclosporin (CSP) and either methylprednisolone (MP) or methotrexate (MTX) have been useful in the prophylaxis of acute graft-versus-host…”
Get more information

Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy by Wetzler, M, Baer, M R, Bernstein, S H, Blumenson, L, Stewart, C, Barcos, M, Mrózek, K, Block, A W, Herzig, G P, Bloomfield, C D

“…c-mpl, the human homolog of v-mpl, is the receptor for thrombopoietin. Given that c-mpl expression carries an adverse prognosis in myelodysplastic syndrome and…”
Get more information

High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation of severe myelosuppressive therapy : a study of the american bone marrow transplant group by WOLFF, S. N, FAY, J. W, HERZIG, R. H, GREER, J. P, DUMMER, S, BROWN, R. A, COLLINS, R. H, STEVENS, D. A, HERZIG, G. P

“…To determine whether intravenous immunoglobulin (IVIG) prevents severe infections during autologous bone marrow transplantation or equivalent high-dose…”
Get full text

High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results by Wolff, S N, Herzig, R H, Fay, J W, Phillips, G L, Lazarus, H M, Flexner, J M, Stein, R S, Greer, J P, Cooper, B, Herzig, G P

“…In an effort to increase the proportion of patients with acute myeloid leukemia (AML) remaining in continued complete remission (CCR), we administered…”
Get more information

Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation by Leventhal, Joseph, Abecassis, Michael, Miller, Joshua, Gallon, Lorenzo, Ravindra, Kadiyala, Tollerud, David J, King, Bradley, Elliott, Mary Jane, Herzig, Geoffrey, Herzig, Roger, Ildstad, Suzanne T

“…The toxicity of chronic immunosuppressive agents required for organ transplant maintenance has prompted investigators to pursue approaches to induce immune…”
Get more information

Amphotericin B-resistant yeast infection in severely immunocompromised patients by Powderly, W G, Kobayashi, G S, Herzig, G P, Medoff, G

“…Systemic yeast infections are a major cause of morbidity and mortality in severely immunocompromised patients. The in vitro susceptibility to amphotericin B of…”
Get more information

Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation by SCHRIBER, J, MILK, B, SHAW, D, CHRISTIANSEN, N, BAER, M, SLACK, J, TEZCAN, H, WETZLER, M, HERZIG, G

“…The treatment of established veno-occlusive disease (VOD) of the liver with tissue plasminogen activator (tPA) has been disappointing. In attempts to improve…”
Get full text

Interferon‐α‐associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy by Shah, Manisha, Jenis, Edwin H., Mookerjee, Basab K., Schriber, Jeffrey R., Baer, Maria R., Herzig, Geoffrey P., Wetzler, Meir

“…BACKGROUND Acute renal failure, with or without massive proteinuria, is a rare idiosyncratic toxicity of interferon (IFN)‐α therapy. The authors sought to…”
Get full text